Data as of Oct 28, 2026.

vsCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Across categories

IBB vs VUSB: Differences, Returns & Fees

Share
Share on XDownload as PDF

Over the year to Oct 28, 2026, IBB returned +37.5% to VUSB's +3.5%, and VUSB charges 0.10% to IBB's 0.44%.

askIQ about this page

askIQ about IBB and VUSB

Net assets: $11.0bn on Oct 27, 2026 for iShares Biotechnology ETF, and $9.9bn on Sep 30, 2026 for Vanguard Ultra-Short Bond ETF.

At a glance
+37.5%
IBB total return, 1 year
+3.5%
VUSB total return, 1 year
0.44%
IBB expense ratio
0.10%
VUSB expense ratio

Pair scorecard

VUSB costs 0.34 points a year less; their one-year returns differ by 34.0 points; IBB is 1.1 times larger.

IBB vs VUSB: Differences, Returns & Fees
MeasureIBBVUSB
Return
Total return, 1 year+37.5%+3.5%
Benchmark
What it tracksBiotechNo index, actively managed
Cost and size
Expense ratio0.44%0.10%
Net assets, as of Sep 30, 2026$11.2bn$9.9bn
Active share vs the S&P 50099%
Holdings
Holdings in common0%
In the S&P 500, by weight40%
Top ten holdings, share of the fund50%

Holdings in common uses holdings dated Sep 30, 2026 and Oct 27, 2026. Method

What they share

0%

By the books each fund has filed, IBB and VUSB hold 0% of their money in the same securities at the same weight. Holdings dated Sep 30, 2026 and Oct 27, 2026.

0 half 100%

half

0% in common

Positions both hold · largest shared weight first IBB VUSB
Only in one fund ↓
Only in IBB
GILEAD SCIENCES 8.56%
AMGEN INC 8.20%
VERTEX PHARMACEUTICALS 7.53%
REGENERON PHARMACEUTICALS 5.64%
MODERNA 5.29%
NATERA 3.85%
ARGENX SE ADR 3.42%
ILLUMINA INC 2.93%
Only in VUSB
United States Treasury Bill 2.39%
United States Treasury Bill 2.35%
MKTLIQ 2.00%
Regions Bank/Birmingham AL 0.89%
PNC Financial Services Group Inc 0.53%
National Bank of Canada 0.53%
Citizens Bank NA/Providence RI 0.48%
US Bancorp 0.47%
Check overlap with more funds →

Side by side

IBB iShares Biotechnology ETF VUSB Vanguard Ultra-Short Bond ETF
Where it sits Thematic ETF Bond ETF
What it is Biotech Actively managed
Total return, 1 year +37.5% +3.5%
Its benchmark over the same days not measured −1.4% (AGG)
Gap to its benchmark not measured +4.9 pts vs AGG
Expense ratio 0.44% 0.10%
Holdings 245 1344
Net assets, IBB as of Oct 27, 2026 and VUSB as of Sep 30, 2026 $11.0bn $9.9bn

IBB and VUSB on the fields both publish, as of Oct 28, 2026. Source: ETFIQ.

Alert

IBB flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
IBB

By weight, 40% of IBB's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 50% of the fund across 245 positions, as published by its issuer for Oct 27, 2026. Over the year to Oct 28, 2026 the fund returned +37.5% with distributions reinvested.

VUSB

VUSB is actively managed and tracks no index. Over the year to Oct 28, 2026 it returned +3.5% with distributions reinvested, against −1.4% for its benchmark, the Bloomberg U.S. Aggregate Bond Index. The prospectus expense ratio is 0.10% a year.

Questions people ask

Are IBB and VUSB in the same category?
IBB is a thematic ETF and VUSB is a bond ETF, so they do different jobs. The table compares what both publish: return, cost and holdings.
Which returned more over the last year, IBB or VUSB?
In the year to Oct 28, 2026, with distributions reinvested, IBB returned +37.5% and VUSB +3.5%.
Which is cheaper, IBB or VUSB?
VUSB is cheaper, by 0.34 percentage points a year. That is about $34 on $10,000 held for a year. Fees come from each fund's prospectus.
Other comparisons
Cite this pageCitation, APA and Markdown

ETFIQ, IBB against VUSB, data as of Oct 28, 2026. https://etfiq.com/compare/any/ibb-vs-vusb

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.